Market Overview

Global Organ-on-a-Chip (OOC) Market (2018-2023) by Segments, Types, Regions -


The "Worldwide
Organ on a Chip (OOC) Market [by Segments (Devices, Services); by Types
(Lung, Heart, Liver, Intestine, Kidney, Human, Placenta, Gut, Nerve,
Others); by Regions (North America, Europe, APAC, CALA, MEA)]: Sizes and
Forecasts (2018-2023)"
report has been added to's

Drug and pharmaceutical companies lose billions of dollars due to high
drug failure rates in clinical trials, largely due to the current
limitations of using animal models and static cell culture systems.
Coupled with this is the fact that the in-vitro modeling and therapy
development for many diseases is not accurate. This creates a direct
need for clinical modeling that is physiologically relevant to human
organs and at the same time intuitively integrating human-derived cells
with sensor-driven OOC systems.

However, complexities of organ functions aren't easy to model. Creating
an OOC system is a complicated process with multiple hurdles to cross.
Firstly, there is a major need to accurately reproduce the architectural
complexity of organs and tissues in vitro. Then, there is a bigger need
to accurately link them in the correct format for the connected systems
to recapitulate tissue-organ interactions. Solving this is set to be
industry's key priority. OOCs provide tremendous potential if
commercialization is aided by collaborative efforts across the
value-chain and ecosystem. Regulators, medical professionals,
scientists, technicians, and organizations need to collaborate to usher
in the future of medicine through OOCs.

Challenges aside, OOCs offer a possible opportunity to replace current
animal based testing and assessments over time. However, it is unlikely
that OOCs are comprehensive enough to make that change during the
forecast period due to the traditional regulatory requirements and
complexities of organ functions. The current forecast period is the
earliest phase of market adoption for organ-on-a-chip players. The next
decade is a favorable period for upward trend in regulation,
ratification, and adoption. The use of OOCs, as a viable alternative to
traditional clinical lab options, in an improving regulatory environment
and increasing marketplace acceptance, promises to lay the foundation of
the future of accurate medicine.

OOCs are a key piece in the future of personalized medicine, and
collaborative efforts across the ecosystem are key to ensure widespread
adoption. The market opportunity for Organ-on-a-Chip across the globe is
considerable overall.

Companies Featured

  • 4Dcell
  • AxoSim Techologies LLC
  • CN Bio Innovations
  • Cherry Biotech SAS
  • Elvesys
  • Emulate
  • Hepregen
  • Hesperos
  • HREL
  • Insphero
  • Micronit Microtechnologies B.V.
  • Mimetas
  • Nortis
  • Organovo Holdings Inc.
  • Sophion Bioscience
  • Tara Biosystems
  • thinXXS Microtechnology AG
  • TissUse

Key Topics Covered

1 Organ-on-a-Chip: Research Overview and Summary

2 Organ-on-a-Chip: Market Size and Forecast by Segments

3 Organ-on-a-Chip: Market Size and Forecast by Types

4 Organ-on-a-Chip: Market Size and Forecasts by Regions

5 Organ-on-a-Chip: Extended Market Forecasts (2018-2027)

For more information about this report visit

View Comments and Join the Discussion!